Zandi KS[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2003	2
2005	1
2006	1
2024	0

Page 1

Identification of the degradation product of ezlopitant, a non-peptidic substance P antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy.

Kamel AM, Zandi KS, Massefski WW. Kamel AM, et al. Among authors: zandi ks. J Pharm Biomed Anal. 2003 Apr 10;31(6):1211-22. doi: 10.1016/s0731-7085(03)00025-6. J Pharm Biomed Anal. 2003. PMID: 12667937

Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.

Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW. Obach RS, et al. Among authors: zandi ks. Drug Metab Dispos. 2006 Jan;34(1):121-30. doi: 10.1124/dmd.105.006767. Epub 2005 Oct 12. Drug Metab Dispos. 2006. PMID: 16221753

[3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter.

Lowe JA 3rd, Drozda SE, Fisher K, Strick C, Lebel L, Schmidt C, Hiller D, Zandi KS. Lowe JA 3rd, et al. Among authors: zandi ks. Bioorg Med Chem Lett. 2003 Apr 7;13(7):1291-2. doi: 10.1016/s0960-894x(03)00126-4. Bioorg Med Chem Lett. 2003. PMID: 12657266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year